About: Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article (publication date: 27 May 2010)

Attributes	Values
rdf:type	Item
description	articolo scientifico (it) wissenschaftlicher Artikel (de) artículu científicu espublizáu en 2010 (ast) vědecký článek publikovaný v roce 2010 (cs) 2010 թվականի մայիսին հրատարակված գիտական հոդված (hy) 2010 թուականի Մայիսին հրատարակուած գիտական յօդուած (hyw) наукова стаття, опублікована в травні 2010 (uk) vedecký článok (publikovaný 2010/05/27) (sk) article publié dans la revue scientifique British Medical Journal (fr) scientific article (publication date: 27 May 2010) (en) wetenschappelijk artikel (gepubliceerd op 2010/05/27) (nl) مقالة علمية (نشرت في 27-5-2010) (ar)
publication date	wds:Q28751886-758AA1FF-02D1-4AE6-B265-F58601CD8292
publication date	2010-05-27 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q28751886-AF2C94AB-275A-4C36-B464-522A5921FCD6
language of work or name	English
cites work	wds:Q28751886-1069777B-6635-468B-A9E7-246DB1D1EACC wds:Q28751886-182CDA9D-9A9E-4491-9BFC-6AC62C418956 wds:Q28751886-23EAC6E5-27C3-491D-980A-C3B9D45D297D wds:Q28751886-3D08B7D6-7B58-42F8-88AB-2F949CEFD722 wds:Q28751886-50B1A20A-E944-4455-830A-75E5D4A19C38 wds:Q28751886-5205E1C5-E766-495A-BD38-0254B8EC67AD wds:Q28751886-6419621E-5198-48B9-90BF-DD6387CD252B wds:Q28751886-6448F287-8FBD-4B80-800C-ECD2916548C1 wds:Q28751886-6D601481-1A39-4BB5-B73A-50A83C5EE5B9 wds:Q28751886-6FD8B518-C659-448E-A6CE-49A76CCA3E7E wds:Q28751886-704A323B-C384-409F-9F4B-C7484DA1E370 wds:Q28751886-7468F36E-822B-400F-9785-F2FE6EB69A71 wds:Q28751886-7A368BED-EB31-4D9F-AD6E-84C74FDB3C69 wds:Q28751886-7B0CB3CA-6FDC-4B88-9D0A-D3AE7C07CBCC wds:Q28751886-8197173A-D7AE-46EA-8B11-CC372138190A wds:Q28751886-83C954EA-2454-4B79-A838-0A75439B464A wds:Q28751886-95BC108F-62BF-4EA1-ADB8-73141DAAD613 wds:Q28751886-974FFDC0-046F-4989-9601-4CF0025E6B3C wds:Q28751886-AD037FB9-FD12-4F16-86C5-3D9F1852445A wds:Q28751886-C0DDB522-35D3-4EC1-B7E1-9BAE26CB62C8 wds:Q28751886-C4BA856F-FC8D-4857-A3D0-561ED6B43126 wds:Q28751886-D42F3680-4712-47D9-8263-8AF93A509B0A wds:Q28751886-DCE05B14-31B8-4ADB-8B5B-6FFA85E63B7F wds:Q28751886-E0DD6F7A-6A01-4826-82BA-C16FB74B09D7 wds:Q28751886-E33E90BA-F99D-444B-9E67-6B276B348CF1 wds:Q28751886-E56B5100-792D-4C62-9B22-9BEB9117FF7E
cites work	Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study. Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Molecular analysis of an outbreak of influenza in the United Kingdom Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009 Live attenuated versus inactivated influenza vaccine in infants and young children. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. Large trials confirm immunogenicity of H1N1 vaccines Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial. Immunogenicity and tolerability of an AS03(A)-adjuvanted prepandemic influenza vaccine: a phase III study in a large population of Asian adults. Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial. Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination A clinical trial of a whole-virus H5N1 vaccine derived from cell culture. Reproducibility of serologic assays for influenza virus A (H5N1). Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. Interpandemic Influenza in the Houston Area, 1974–76 Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials. Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial. Responses to 2009 H1N1 vaccine in children 3 to 17 years of age. Strategic Advisory Group of Experts on Immunization - report of the extraordinary meeting on the influenza A (H1N1) 2009 pandemic, 7 July 2009 Future of flu vaccines. Expediting clinical trials in a pandemic Recommendations for the administration of influenza vaccine in children allergic to egg.
author name string	wds:Q28751886-0372F697-C82D-491B-8705-76EC89632D29 wds:Q28751886-28B3E6C8-DDE1-4B28-8308-15223C12D16D wds:Q28751886-366213B0-2DAD-4DF3-9405-917300E77160 wds:Q28751886-371ABAD2-349D-48A4-8944-F109DCF25FF1 wds:Q28751886-3827AF17-57A8-4803-8E97-A952B38D82A4 wds:Q28751886-410D409A-769D-4D07-9046-D0090F341723 wds:Q28751886-51928BBC-5F6A-4AAC-A202-54C7543D678F wds:Q28751886-6655B6C4-DF22-4783-8A9B-60FC4E27324A wds:Q28751886-88DC3A40-EA9C-455A-B4D4-011E8A1A38B9 wds:Q28751886-A0079C73-158A-4798-9031-9E7913326D5F wds:Q28751886-A603B8B4-DC87-4480-A37C-367DD0237E97 wds:Q28751886-BFE600F1-500E-4865-8A0D-AEA423C36CD8 wds:Q28751886-D1558B1D-700F-48C7-9514-1481E153F216 wds:Q28751886-D67852C2-0D06-4C6F-A80E-6F75EB46C33A wds:Q28751886-F8FD7069-D0B3-4E84-8CA5-7674C235564E wds:Q28751886-F97CF49F-64B7-48D9-B1D7-A16292AE7033
OpenCitations bibliographic resource ID	wds:Q28751886-6B05DC39-19AD-40DF-AEEE-15F9746F8DAC
OpenCitations bibliographic resource ID	https://w3id.org/oc/corpus/br/3114644
author name string	E Miller A Reiner R J Allen M Casey A Finn P T Heath T John I Okike C Oeser S Wilkins P Waight A C Collinson E Sheasby

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software